COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,159 Articles (22,703 medRxiv, 8,456 bioRxiv)

Most recent first Previous |  Page 64: Articles 631-640  | Next

Effectiveness of the 2023 Autumn XBB.1.5 COVID-19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study
Humphreys, J., Nicolay, N., Braeye, T., Van Evercooren, I., Holm Hansen, C., Rask Moustsen-Helms, I., Sacco, C., Fabiani, M., Castilla, J., Martinez-Baz, I., Machado, A., Soares, P., Ljung, R., Pihlstrom, N., Kissling, E., Nardone, A., Monge, S., Bacci, S., Nunes, B., VEBIS-EHR working group
10.1101/2025.04.30.25326709 — Posted: 2025-05-01
A Tale of Three (Major) Cities: Trends in Covid-19 Firearm Deaths Pre- vs. Post-Pandemic
Cardone, C., Kilpatrick, A., Bunker, S., Ledet, R., Duran, M., Coello-Sanchez, C., D'Amico, M., Richman, M.
10.1101/2025.04.28.25326367 — Posted: 2025-05-01
Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1
Guo, C., Yu, Y., Liu, J., Jian, F., Yang, S., Song, W., Shao, F., Yu, L., Cao, Y.
10.1101/2025.04.30.651462 — Posted: 2025-05-01
RECUR: Identifying recurrent amino acid substitutions from multiple sequence alignments
Robbins, E. H., Liu, Y., Kelly, S.
10.1101/2025.04.29.651261 — Posted: 2025-04-30
Kozak sequence libraries for characterizing transgenes across expression levels
Shukla, N., Kamath, N. D., Snell, J. C., Bruchez, A. M., Matreyek, K. A.
10.1101/2025.04.28.651141 — Posted: 2025-04-30
MAVS Orchestrates a Potent IFN-independent Antiviral Immunity by Preserving Mitochondrial Integrity
Sah, V., Potharaju, P. S., Nair, K. S., Sahoo, P. P., Pooja, A. R., Basu, D., Tandel, D., Varadarajan, K. S., Chauhan, S., Patel, A. B., Harshan, K. H.
10.1101/2025.04.28.651145 — Posted: 2025-04-30
Long-COVID Postural Tachycardia Syndrome: A deep phenotyping study
Larsen, N. W., Machnik, J. V., Seliger, J., Shaik, R., Gibbons, C. H., Utz, P. J., Lansberg, M. G., Muppidi, S., Jaradeh, S., Miglis, M. G.
10.1101/2025.04.28.25326587 — Posted: 2025-04-29
Prevalence of Long COVID in Mycobacterium tuberculosis-Exposed Groups in Peru and Kenya
Ongaya, A., Cardenas Jara, A. R., Likhovole, C. R., Ramos, L. B., Senador, L., Flores, J. A., Kanoi, B., Reijneveld, J. F., Ruvalcaba, A., Perez, D., Waiganjo, P., Lindestam Arlehamn, C. S., Henrich, T. J., Peluso, M. J., Leon, S. R., Gitaka, J., Suliman, S.
10.1101/2025.04.28.25326537 — Posted: 2025-04-29
Frequency, Dynamics, and Duration of Fecal Shedding in SARS-CoV-2 Infected Individuals, a Scoping Review
Buchholz, U., Abunijela, S., Greiner, T., Haas, W., Schattschneider, A., Puetz, P., Kerber, R., Schumacher, J.
10.1101/2025.04.29.25326628 — Posted: 2025-04-29
Return to Work with Long COVID: A Rapid Review of Support and Challenges
Daniels, S., Wei, H., McElvenny, D. M., van Tongeren, M., Bramwell, D., Coleman, A., Forde, D., Wiggans, R.
10.1101/2025.04.29.25326647 — Posted: 2025-04-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).